Abstract:All-trans-retinoic acid (ATRA), the biologically most active metabolite of vitamin A, plays a major role in the regulation of cellular differentiation and proliferation, and it is also an important pharmacological agent particularly used in the treatment of cancer, skin, neurodegenerative and autoimmune diseases. However, ATRA is very easy to be metabolized into 4-hydroxyl-RA in vivo by CYP26A1, an inducible cytochrome P450 enzyme, eventually into more polar metabolites. Therefore, it is vital to develop specific retinoic acid metabolism blocking agents (RAMBAs) to inhibit the metabolic enzyme CYP26A1 in the treatment of relevant diseases aforementioned.In this study, CYP26A1 and its interactions with retinoic acid-competitive metabolism blocking agents were investigated by a combined ligand- and structure-based approach. First, since the crystal structure of CYP26A1 protein has not been determined, we constructed the 3D structure of CYP26A1 using homology modeling. In order to achieve a deeper insight into the mode of action of RAMBAs in the active site, the molecular superimposition model and the common feature pharmacophore model were constructed, and molecular docking was performed. The molecular superimposition model is composed of three features: the main chain groups, side chain groups, and azole groups. The common feature pharmacophore model consists of five chemical features: four hydrophobic groups and one hydrogen acceptor (HHHHA). The results of molecular docking show that the characteristic groups of RAMBAs were mapped into three different active pockets, respectively.A structure-activity relationship (SAR) was obtained by a combination of the molecular superimposition and docking results with the pharmacophore model. This study gives more insight into the interaction model inside the CYP26A1 active site and provides guidance for the design of more potent and possibly more selective RAMBAs. (C) 2014 Elsevier Inc. All rights reserved.

Mass-spectrometric Analysis of Agonist-Induced Retinoic Acid Receptor Γ Conformational Change

Molecular Recognition of CYP26A1 Binding Pockets and Structure–activity Relationship Studies for Design of Potent and Selective Retinoic Acid Metabolism Blocking Agents

Monitoring conformational changes in peroxisome proliferator-activated receptor α by a genetically encoded photoamino acid, cross-linking, and mass spectrometry

A Mass Spectrometry-Based Structural Assay for Activation-Dependent Conformational Changes in beta-Arrestins

G Protein-Coupled Estrogen Receptor (Gper) Agonist Dual Binding Mode Analyses Toward Understanding Of Its Activation Mechanism: A Comparative Homology Modeling Approach

Molecular Interactions of Selective Agonists and Antagonists with the Retinoic Acid Receptor γ

Molecular Mechanism of Action of RORγt Agonists and Inverse Agonists: Insights from Molecular Dynamics Simulation

The Effect of Antagonists on the Conformational Exchange of the Retinoid X Receptor Alpha Ligand-Binding Domain

Multiple Ligand-Specific Conformations of the Β2-Adrenergic Receptor

Probing the Conformation States of Neurotensin Receptor 1 Variants by NMR Site-Directed Methyl Labeling

Investigations of Retinoic Acid Receptor-Related Orphan Receptor-Gamma T (rorγt) Agonists: a Combination of 3D-QSAR, Molecular Docking and Molecular Dynamics

Identification of Distinct, Ligand‐specific Structural Changes in a G Protein‐coupled Receptor

Distinct Structural Changes in a G Protein-coupled Receptor Caused by Different Classes of Agonist Ligands

Conventional Receptor Radioligand Binding Techniques Applied to the Study of Monoamine Oxidase

Quantitative Profiling of Endogenous Retinoic Acid in Vivo and in Vitro by Tandem Mass Spectrometry.

The conformational equilibria of a human GPCR compared between lipid vesicles and aqueous solutions by integrative 19F-NMR

Unbinding of Retinoic Acid from its Receptor Studied by Steered Molecular Dynamics

Ligand modulation of sidechain dynamics in a wild-type human GPCR

Screening, deconvolution and parallel synthesis of trisubstituted piperazine and trisubstituted 2,3-diketopierazine libraries for the rapid identification of antagonists of the nuclear retinoic acid receptor-related orphan receptor gamma (RORγ)

Mapping Angiotensin II Type 1 Receptor-Biased Signaling Using Proximity Labeling and Proteomics Identifies Diverse Actions of Biased Agonists

Molecular Dynamics Simulations on RORγt: Insights into Its Functional Agonism and Inverse Agonism